Difference between revisions of "Amodiaquine"
(clean up using AWB) |
m (1 revision) |
(No difference)
| |
Latest revision as of 10:13, 20 September 2010
| File:Amodiaquine.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
4-[(7-chloroquinolin-4-yl)amino]-2-[(diethylamino)methyl]phenol | |
| Pharmacokinetic data | |
| Biological half-life | 5.2 ± 1.7 (range 0.4 to 5.5) minutes |
| Identifiers | |
| CAS Number | 86-42-0 |
| ATC code | P01BA06 (WHO) |
| PubChem | CID 2165 |
| DrugBank | APRD00796 |
| ChemSpider | 2080 |
| Chemical data | |
| Formula | C20H22ClN3O |
| Molar mass | 355.861 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
| (verify) | |
Amodiaquine (trade names Camoquin, Flavoquine) is a 4-aminoquinoline compound related to chloroquine, used as an antimalarial and anti-inflammatory agent.
Amodiaquine has been shown to be more effective than chloroquine in treating CRPF (chloroquine-resistant Plasmodium falciparum) malaria infections and may afford more protection than chloroquine when used as weekly prophylaxis. Amodiaquine, like chloroquine, is generally well tolerated. Although licensed, this drug is not marketed in the United States but is widely available in Africa. Its use, therefore, is probably more practicable in long-term visitors and persons who will reside in Africa.[1]
Amodiaquine is a histamine N-methyltransferase inhibitor.
Notes
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 50px | This antiinfective drug article is a stub. You can help ssf by expanding it. |
- Pages with script errors
- Pages using duplicate arguments in template calls
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Antimalarial agents
- Quinolines
- Phenols
- Organochlorides
- Antiinfective agent stubs
- 2Fix
